SCHEMBL17065826

SCHEMBL17065826

COc1cc2ccccc2c(N(C)Cc2ccccc2)c1Br

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 2/20 0.41
PIM1 P11309 1/20 0.41
RXFP1 Q9HBX9 1/20 0.40
ACHE P22303 4/20 0.39
HTR1D P28221 1/20 0.39
HTR1B P28222 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
POLB P06746 1/20 0.38
BCHE P06276 2/20 0.38
PDE5A O76074 1/20 0.37
PIK3CD O00329 1/20 0.37
LMNA P02545 1/20 0.37
PIK3R1 P27986 1/20 0.37
HIF1A Q16665 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
KIT P10721 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17065827 0.81 PIM1 (0.40) KDM4EMAPTHTTPIM1HTR1D
SCHEMBL17065838 0.77 NQO1 (0.40) KDM4EGAAMAPTACHESMN1; SMN2
SCHEMBL17065819 0.74 KMT2A (0.47) KDM4EMAPTHTTPIM1HTR1D
SCHEMBL17065824 0.74 CALM1 (0.43) RXFP1ACHEBCHE
SCHEMBL5460840 0.70 NQO1 (0.47) KDM4EMAPTSMN1; SMN2POLBLMNA
SCHEMBL17065825 0.68 ATM (0.40) KDM4EMAPTHTTPIM1SMN1; SMN2
SCHEMBL30065634 0.66 ALDH1A1 (0.47) KDM4EMAPTSMN1; SMN2LMNAHIF1A
SCHEMBL13302148 0.66 PTGES (0.48) KDM4EMAPTSMN1; SMN2POLBLMNA
SCHEMBL19617285 0.66 ALDH1A1 (0.47) KDM4EMAPTSMN1; SMN2LMNAHIF1A
SCHEMBL11136125 0.66 KDM4E (0.50) KDM4EGAAMAPTACHESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3113768-A1 USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS Universita' Degli Studi Di Pavia (IT) 2017-01-11 EP disclosed
WO-2015132733-A1 USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS UNIVERSITA' DEGLI STUDI DI PAVIA (IT) 2015-09-11 WO disclosed